AI-Powered Antibiotic Discovery: Machine Learning Models Show Promise for Rapidly Designing New Drugs to Combat Antimicrobial Resistance
-
The global burden of antimicrobial resistance is rising, necessitating new approaches to antibiotic discovery.
-
Machine learning methods like generative models show promise for designing novel antibiotic chemical structures.
-
Models must be designed to generate molecules that are synthetically accessible and structurally sound.
-
Generated molecules should be evaluated for desired pharmacological properties like antibacterial activity.
-
Promising AI-designed molecules could accelerate traditional experimental pipelines to discover new antibiotics.